Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1984 3
1985 11
1986 10
1987 9
1988 3
1989 6
1990 5
1991 6
1992 4
1993 12
1994 7
1995 15
1996 23
1997 15
1998 12
1999 6
2000 10
2001 3
2002 8
2003 10
2004 9
2005 15
2006 11
2007 9
2008 15
2009 8
2010 6
2011 5
2012 7
2013 6
2014 8
2015 5
2016 12
2017 7
2018 5
2019 5
2020 5
2021 6
2022 7
2023 8
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

314 results

Results by year

Filters applied: . Clear all
Page 1
Targeted therapies for rare gynaecological cancers.
Manchana T, Ittiwut C, Mutirangura A, Kavanagh JJ. Manchana T, et al. Among authors: kavanagh jj. Lancet Oncol. 2010 Jul;11(7):685-93. doi: 10.1016/S1470-2045(09)70368-7. Epub 2010 Mar 31. Lancet Oncol. 2010. PMID: 20362508 Review.
Hormonal therapy in ovarian cancer.
Zheng H, Kavanagh JJ, Hu W, Liao Q, Fu S. Zheng H, et al. Among authors: kavanagh jj. Int J Gynecol Cancer. 2007 Mar-Apr;17(2):325-38. doi: 10.1111/j.1525-1438.2006.00749.x. Int J Gynecol Cancer. 2007. PMID: 17362310 Review.
Anticancer therapy targeting the apoptotic pathway.
Hu W, Kavanagh JJ. Hu W, et al. Among authors: kavanagh jj. Lancet Oncol. 2003 Dec;4(12):721-9. doi: 10.1016/s1470-2045(03)01277-4. Lancet Oncol. 2003. PMID: 14662428 Review.
Venous thromboembolism syndrome in gynecological cancer.
Wang X, Fu S, Freedman RS, Kavanagh JJ. Wang X, et al. Among authors: kavanagh jj. Int J Gynecol Cancer. 2006 Jan-Feb;16 Suppl 1:458-71. doi: 10.1111/j.1525-1438.2006.00515.x. Int J Gynecol Cancer. 2006. PMID: 16515646 Review.
Targeted therapies in gynecologic cancers.
Chon HS, Hu W, Kavanagh JJ. Chon HS, et al. Among authors: kavanagh jj. Curr Cancer Drug Targets. 2006 Jun;6(4):333-63. doi: 10.2174/156800906777441799. Curr Cancer Drug Targets. 2006. PMID: 16848724 Review.
Uterine Neoplasms. Clinical Practice Guidelines in Oncology.
Greer BE, Koh WJ, Abu-Rustum N, Bookman MA, Bristow RE, Campos SM, Cho KR, Copeland L, Crispens MA, Eifel PJ, Huh WK, Jaggernauth W, Kapp DS, Kavanagh JJ, Lurain JR 3rd, Morgan M, Morgan RJ, Powell CB, Remmenga SW, Reynolds RK, Alvarez Secord A, Small W Jr, Teng N. Greer BE, et al. Among authors: kavanagh jj. J Natl Compr Canc Netw. 2009 May;7(5):498-531. doi: 10.6004/jnccn.2009.0035. J Natl Compr Canc Netw. 2009. PMID: 19460278 Review. No abstract available.
Proteomics in cancer research.
Wu W, Hu W, Kavanagh JJ. Wu W, et al. Among authors: kavanagh jj. Int J Gynecol Cancer. 2002 Sep-Oct;12(5):409-23. doi: 10.1046/j.1525-1438.2002.01200.x. Int J Gynecol Cancer. 2002. PMID: 12366655 Review.
Ethics guidelines for research with the recently dead.
Pentz RD, Cohen CB, Wicclair M, DeVita MA, Flamm AL, Youngner SJ, Hamric AB, McCabe MS, Glover JJ, Kittiko WJ, Kinlaw K, Keller J, Asch A, Kavanagh JJ, Arap W. Pentz RD, et al. Among authors: kavanagh jj. Nat Med. 2005 Nov;11(11):1145-9. doi: 10.1038/nm1105-1145. Nat Med. 2005. PMID: 16270065
314 results